Category Archives: Cancer Treatment

Eric Lefkofsky: Fighting Cancer with New Technologies

Cancer is one of the deadliest diseases in the history of humanity. For ages, it has claimed the lives of billions of people. The disease is very tricky, as it conditions the body that having cancer is a normal function inside the body until it gives out its final blow killing of victim. Scientists around the world have been working together to fight off the disease, and one man named Eric Lefkofsky has even founded a tech company only dedicated to putting an end to cancer. Tempus Labs was established to improve the way on how patients who are suffering from cancer can be diagnosed and eventually treated. Eric Lefkofsky stands as the company’s chief executive officer, and he managed to propel the company to become one of the top tech companies in Chicago.

Tempus Labs gather data from different cancer patients around the world. With the technology that Eric Lefkofsky developed, the company can organize all of the data sent to them and formulating various ways on how to diagnose future patients who will develop the disease. Through the gathering and organizing of data, it is possible that Tempus Labs will be able to develop the best treatment for a particular patient. It is also lauded by scientists because Tempus Labs allow the storage of sensitive data that can end up being lost or destroyed.

The traditional medical record of patients with cancer has been used repeatedly for ages because doctors can just look at the symptoms and judge whether the patient is having the same kind of disease. With the technology developed by Tempus, it is possible for the patient data to be analyzed by the computer, and new patterns and algorithms will be developed to personalize the treatment method for a patient. It is an amazing technology, and Eric Lefkofsky thanked everyone who helped him realize the project.

Eric Lefkofsky is hoping that the technology he created would save lives in the future. He is also putting his trust to future scientists in improving the project that he created. Tempus Labs continues to gather data, and it now has a gargantuan data storage facility that has millions of data stored.

For details:

Clay Siegall, Improving The Lives Of Cancer Patients

Clay Siegall is the co-founder of Seattle Genetics since 1998. He started the company with the idea of improving people’s lives by using targeted therapies to kill cancer cells. Clay Siegall is a trained scientist who built Seattle Genetics to develop drug practices, perform extensive research and improve your quality of life. Under his leadership he has helped Seattle Genetics create ADCETRIS, their first FDA approved product for the treatment of cancer. ADCETRIS is a global brand that is currently approved in over 70 countries. They have also entered into multiple licenses for their ADCETRIS technology, including AbbVie, Pfizer, Astellas, GlaxoSmithKline and Genentech (Roche). Using Seattle Genetics’ technology, there are more than 20 ADC’s currently in clinical development. Clay Siegall is also responsible for the capital-raising activities for Seattle Genetics. He has helped secure over $1 billion through private and public financing. Clay has worked for the National Institutes of Health, National Cancer Institute and the Bristol-Myers Squibb Pharmaceutical Research Institute. He has been honored with the University of Maryland Alumnus of the Year for Computer, Math and Natural Sciences award and the 2012 Pacific Northwest Ernst & Young Entrepreneur of the Year award. He has written over 70 publications and graduated from George Washington University with a Ph.D. in Genetics. Siegall also have a B.S. in Zoology from the University of Maryland.

Seattle Genetics is one of the largest oncology biotechnology company in the Pacific Northwest. Their innovative ADC technology combines potent cell eliminating agents, linker systems and monoclonal antibodies to kill cancer. Seattle Genetics has proven to improve the outcomes of their patients living with cancer. They are becoming the leader in transforming cancer therapy through its advanced research into ADC technology.